BIOLASE ANNOUNCES FDA CLEARANCE OF ITS OCULASE MD LASER SYSTEM FOR OPHTHALMOLOGY

BIOLASE Technology, Inc., a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) allowing it to market its OCULASE MD(TM) Laser System for general ophthalmic soft tissue surgical indications. Biolase (http://www.biolase.com/news.html)